Journal
NEUROBIOLOGY OF AGING
Volume 30, Issue 5, Pages 739-751Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2007.08.022
Keywords
Frontotemporal dementia; FTDP-17; Progranulin; PGRN; MRI
Categories
Funding
- National Institute on Aging [AG06786, AG16574, AG11378, AG07216]
- Mayo Foundation
- Fund for Scientific Research Flanders (FWO-F)
- Medical Research Council [G0701441, G0600984, G0400356] Funding Source: researchfish
- MRC [G0400356, G0701441, G0600984] Funding Source: UKRI
Ask authors/readers for more resources
Mutations in progranulin (PGRN) are associated with frontotemporal dementia with or without parkinsonism. We describe the prominent phenotypic variability within and among eight kindreds evaluated at Mayo Clinic Rochester and/or Mayo Clinic Jacksonville in whom mutations in PGRN were found. All available clinical, genetic, neuroimaging and neuropathologic data was reviewed. Age of onset ranged from 49 to 88 years and disease duration ranged from I to 14 years. Clinical diagnoses included frontotemporal dementia (FTD), primary progressive aphasia, FTD with parkinsonism, parkinsonism, corticobasal syndrome, Alzheimer's disease, amnestic mild cognitive impairment, and others. One kindred exhibited maximal right cerebral hemispheric atrophy in all four affected individuals, while another had maximal left hemisphere involvement in all three of the affected. Neuropathologic examination of 13 subjects revealed frontotemporal lobar degeneration with ubiquitin-positive inclusions plus neuronal intranuclear inclusions in all cases. Age of onset, clinical phenotypes and MRI findings associated with most PGRN mutations varied significantly both within and among kindreds. Some kindreds with PGRN mutations exhibited lateratized topography of degeneration across all affected individuals. (C) 2007 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available